Theremia
Latest round
- Seed
Last raised
- Jun 2025
Total raised
- $2.3M
Investors
- 5
About Theremia
Based in France, Theremia develops advanced precision medicine solutions focused on central nervous system diseases, particularly mental health.Theremia, founded in 2024, is headquartered in Paris, France. The company specializes in precision medicine solutions targeting CNS diseases.Theremia specializes in precision medicine solutions aimed at addressing central nervous system (CNS) diseases, particularly focusing on mental health disorders such as major depressive disorders. The company utilizes advanced machine learning models to analyze extensive health data, enabling a nuanced understanding of patient-specific drug responses based on factors such as gender, age, and ethnicity. Theremia collaborates closely with biotech companies to integrate these insights at every stage of treatment development, enhancing the precision of drug prescribing and treatment customization. Their services include the development of tools for early diagnosis, patient monitoring solutions, and prevention programs tailored to diverse demographic groups.The revenue structure of Theremia primarily revolves around partnerships with biotech companies and healthcare providers, leveraging a business-to-business (B2B) model. Transactions generally occur through collaborative agreements that encompass subscription-based access to their analytical platforms and tools, which facilitate the integration of real-world evidence into treatment strategies. Clients typically consist of healthcare institutions and pharmaceutical companies, which utilize Theremia's services to develop tailored therapeutic approaches and improve patient adherence to treatments. The company's flagship offerings are designed to enhance the efficacy of CNS treatments while addressing the critical issue of adverse drug reactions. The company plans to launch new products aimed at improving mental health treatment, although specific release dates have not been disclosed. Theremia is targeting expansion into broader European markets, capitalizing on increased demand for mental health solutions.
Who invested in Theremia
5 investors across 1 round
See all investors in Theremia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 13, 2025
Amount
$2.3M
Investors
Questions about Theremia
Who invested in Theremia?
Theremia has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Theremia raised?
Theremia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Theremia last raise money?
Theremia's most recent round on record is a Seed, in Jun 2025.
What does Theremia do?
Based in France, Theremia develops advanced precision medicine solutions focused on central nervous system diseases, particularly mental health.
Where is Theremia headquartered?
Theremia is headquartered in Paris, France.
Which VCs invest in companies like Theremia?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare it companies at Theremia's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Theremia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.